Navigation Links
New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Association's Scientific Sessions
Date:11/11/2010

RIDGEFIELD, Conn., Nov. 11, 2010 /PRNewswire/ -- Results of two pre-specified sub-study analyses of the 18,113 patient RE-LY® trial,(1) involving the newly approved oral anticoagulant Pradaxa® (dabigatran etexilate mesylate) capsules,(2) will be presented at the American Heart Association's Annual Scientific Sessions on Monday, November 15, 2010.  The analyses assessed the prognostic value of two separate biomarkers (D-dimer and NT-proBNP) for predicting cardiovascular events in patients with non-valvular atrial fibrillation (AFib).(3,4)

RE-LY® was a global, Phase III, randomized trial, which investigated whether PRADAXA was as effective as well-controlled warfarin (open label) for stroke prevention in patients with non-valvular atrial fibrillation.(1) The study provided the basis for the U.S. Food and Drug Administration's (FDA) recent approval of PRADAXA to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.(2)

Well-controlled warfarin, defined as INR 2.0 – 3.0, has been shown to reduce the risk of stroke in patients with non-valvular atrial fibrillation.(5)  Results of the RE-LY® trial demonstrated PRADAXA 150mg taken twice daily significantly reduced stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin.(2) PRADAXA 150mg taken twice daily also significantly reduced both ischemic and hemorrhagic strokes compared to warfarin.(2)

PRADAXA is the only approved oral anticoagulant that has been shown to significantly reduce the risk of stroke compared to warfarin(2) and is the first oral anticoagulant to be approved in the U.S. in more than 50 years.  PRADAXA is now available in more than 35,000 pharmacies nationwide.  

About RE-LY®

RE-LY® was a global, Phase III, randomized trial(1) of 18,113 patients(1) enrolled in 951 centers in 44 countries,(6) investigating whether PRADAXA (two b
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
6. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
10. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN ) ... interview with ABC TV that was broadcast on Saturday September ... the following day on Weekend Breakfast. The interview concerned the ... clinic in Australia for the treatment ... The interview provides certain new information and is being ...
(Date:9/29/2014)... , Sept. 29, 2014  Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, announced today the closing of ... As previously disclosed, Lpath sold 3,605,042 registered shares ... unregistered shares of common stock in a registered ... per share-and-warrant-share combination.  The warrants have an exercise ...
(Date:9/29/2014)... Sept. 29, 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... its previously announced public offering of 20,930,000 shares of ... underwriters, full exercise of their option to purchase additional ... per share, before underwriting discounts. J.P. Morgan, Deutsche Bank ... managers for the offering. Piper Jaffray and ...
Breaking Medicine Technology:ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 2ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 3Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 3Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 3
... Symmetry Medical Inc. (NYSE: SMA ), a leading ... and other medical markets, announced today that it has entered ... November 3, 2010.  The credit facility includes an "accordion feature" ... million. The credit facility has a term of five years. ...
... Nov. 3, 2010 Aethlon Medical, Inc. (OTC ... in developing therapeutic filtration devices to address infectious ... present tomorrow at the at the Singular Research ... Los Angeles. (Photo:   http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) ...
Cached Medicine Technology:Symmetry Medical Closes $200 Million Credit Facility 2Symmetry Medical Closes $200 Million Credit Facility 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 2Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 4
(Date:9/29/2014)... 2014 NAPW honors ... of Private Pediatrics of Palm Beach as ... recognized for leadership in pediatrics and family care with ... women in the country, spanning virtually every industry and ... a powerfully vibrant networking community with over 600,000 members ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Top10BestSEOHosting.com has recently compared many Linux ... ) and Bluehost are the most recommended suppliers ...
(Date:9/29/2014)... FL (PRWEB) September 29, 2014 Every ... the school year, cross country running season takes off! ... the fall cross country running season. Zensah®, the leading ... sleeves and compression socks for cross ... cross country runners to reduce delayed onset muscle soreness ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... D.C. September 30, 2014 (PRWEB) September 29, 2014 ... devices like smartphones, tablets and laptops provides the delivery ... all ages, from youth to adult, to raise and ... obtain professional licensure, or to obtain certification in your ... an educated workforce to compete effectively and at MMU ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 2Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 3
... Academy of Family Physicians today announced the Consumer Alliance, ... partner, The Coca-Cola Company. , (Logo: ... program that allows corporate partners like The Coca-Cola Company ... the role their products can play in a healthy, ...
... CAMBRIDGE, Mass., Oct. 6 Galenea Corp., a fully-integrated ... been awarded an NIH Challenge Grant in Health and ... and Reinvestment Act of 2009 (Recovery Act). This ... addresses the specific topic of "Screening Approaches to Identify ...
... HOSPITAL ROOM , New research shows that certain noninvasive ... up to a distance of 1 m from patients ... spread of highly contagious respiratory illness within the hospital ... with mild lung injury, researchers from Hong Kong measured ...
... ... to earn continuing education credits , , ... Lincoln, NE (Vocus) October 5, 2009 -- The online ... Solutions (HES) recently received approval from the American Academy of Family Physicians (AAFP). The ...
... Speaker Nancy Pelosi issued the following statement congratulating molecular ... Francisco, who today was named to receive the 2009 Nobel ... W. Greider of Johns Hopkins University School of Medicine and ... of an enzyme that plays a key role in normal ...
... Superhero, to Feature DJ Cut Chemist, Violinist Lili Haydn, The ... Choir, The Raretones and Bells of the Sound , ... Symphony Guild today announced the artist lineup ... annual event which benefits Seattle Children,s Hospital ...
Cached Medicine News:Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 2Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 3Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 4Health News:Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition 2Health News:News briefs from the October issue of Chest 2Health News:Health Education Solutions' Advanced Cardiac Life Support Course Gains Approval from American Academy of Family Physicians 2Health News:The Symphony Guild Announces Artist Lineup for 2009 Event 2Health News:The Symphony Guild Announces Artist Lineup for 2009 Event 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: